According to a 2010 report by the Centers for Disease Control.

The follow-up study, Association Between Treatment of Systolic Hypertension and Long-Term Survival was published on the web today in the Journal of the American Medical Association. Almost 22 years after the initiation of the SHEP trial, we are able to confirm the legacy aftereffect of treating hypertension, in the elderly particularly. We report that the common patient would live one day longer for every month of treatment. This may match greater than a year for those who start treatment within their fifties, said John B. Kostis, MD, the John G. Detwiler Chair of Cardiology, seat of the department of medication, and founding director of The Cardiovascular Institute of NJ, who led the study.The CDC says Chikungunya, Swahili for ‘whatever bends up’, was initially isolated in the blood of a febrile individual in Tanzania in 1953.

America’s vision woes on rise: Blame diabetes? An increasing number of Americans have shed their eyesight recently, and a new study shows diabetes could be to blame. Diabetes: 5 dumb methods to increase your risk New study highlights lifestyle options that increase risk for common metabolic disease The new analysis finds that the number of U.S. Adults who are losing their vision has climbed more than 20 % over the past decade, rates that were more pronounced in younger adults even.

Other entries from category "endocrinology":

Random entries